KennethFManganMD

PubMed

• 6 citations
  Donor Lymphocyte Infusion in Hematologic Malignancies—Good to be Fresh?
  Nasheed Hossain, Thomas R. Klumpp, John Ulicny, Michael Garner, Patricia Kropf, Mangan Kf, Stefan K. Barta, Henry C. Fung, Mary Ellen Martin> ;Clinical Lymphoma, Myeloma & Leukemia. 2016 Feb 1
• Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation.
  Giralt, S. A., Mangan, K. F., Maziarz, R. T., Bubalo, J. S., Beveridge, R., Hurd, D. D., Mendoza, F. L., Rubenstein, E. B., DeGroot, T. J., Schuster, M. W.> ;Ann Oncol. 2011 Apr
• Sudden loss of the GVL effect following use of the TNF inhibitor infliximab in a chronic myelogenous leukemia patient with chronic GVHD.
  Veeraputhiran, M., Mangan, K.> ;Bone Marrow Transplant. 2010 Jun 01
• 14 citations
  T-cell chronic lymphocytic leukaemia: anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2'-deoxycoformycin).
  A. S. D. Spiers, M. P. Davis, Marilyn Levine, C. Y. Li, Kenneth F. Mangan, J. J. Mazza, L. T. Neu, J. O'Brien, A. E. Rauch, J. C. Wiltsie, Leslie Bieler, Carol A. Lorch> ;Scandinavian Journal of Haematology. 2009 Apr 24
• Palonosetron (PALO) for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose melphalan prior to stem cell transplant (SCT).
  Giralt S, Mangan K, Maziarz R, Bubalo JS, Beveridge R, Hurd DD, Mendoza F, Rubenstein EB, DeGroot TJ, Schuster MW> ;J. Clin. Oncol.. 2008-05-20
• Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation.
  Klumpp, T. R., Herman, J. H., Ulicny, J., Emmons, R. V., Martin, M. E., Mangan, K. F.> ;Bone Marrow Transplant. 2006 Nov
• Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients.
  Lewis, N. L., Mullaney, M., Mangan, K. F., Klumpp, T., Rogatko, A., Broccoli, D.> ;Bone Marrow Transplant. 2004 Jan
• Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast ...
  Schulman, K. A., Stadtmauer, E. A., Reed, S. D., Glick, H. A., Goldstein, L. J., Pines, J. M., Jackman, J. A., Suzuki, S., Styler, M. J., Crilley, P. A., Klumpp, T. R....> ;Bone Marrow Transplant. 2003 Feb
• Severe cutaneous ulceration following treatment with thalidomide for GVHD.
  Schlossberg, H., Klumpp, T., Sabol, P., Herman, J., Mangan, K.> ;Bone Marrow Transplant. 2001 Jan
• Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial.
  Ackerman, S. J., Klumpp, T. R., Guzman, G. I., Herman, J. H., Gaughan, J. P., Bleecker, G. C., Mangan, K. F.> ;Transfusion. 2000 Dec
• Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia ...
  Stadtmauer, E. A., O'Neill, A., Goldstein, L. J., Crilley, P. A., Mangan, K. F., Ingle, J. N., Brodsky, I., Martino, S., Lazarus, H. M., Erban, J. K., Sickles, C., Gli...> ;N Engl J Med. 2000 Apr 13
• Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial.
  Klumpp, T. R., Herman, J. H., Gaughan, J. P., Russo, R. R., Christman, R. A., Goldberg, S. L., Ackerman, S. J., Bleecker, G. C., Mangan, K. F.> ;Transfusion. 1999 Jul
• 78 citations
  A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer Patients
  Elizabeth J. Shpall, Catherine Wheeler, Stewart A. Turner, Saul Yanovich, Randy A. Brown, Andrew L. Pecora, Thomas C. Shea, Kenneth F. Mangan, Stephanie F. Williams, C...> ;Blood. 1999 Apr 15
• A rapid two-step method for elimination of bcl-2/IgH positive non-Hodgkin''s lymphoma cells from human blood or marrow stem cells, employing immunomagnetic purging wit...
  Mangan, K. F., Leonardo, J., Mullaney, M. T., Terstappen, L. W., Rao, C., Liberti, P.> ;Cytotherapy. 1999
• Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients.
  Goldberg, S. L., Klumpp, T. R., Magdalinski, A. J., Mangan, K. F.> ;J Clin Oncol. 1998 Dec
• 6 citations
  Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study
  Wolfram E. Samlowski, Danika Lew, Philip J. Kuebler, Michael A. Kolodziej, Jesus E. Medina, Kenneth F. Mangan, Dennis F. Moore, David E. Schuller, John F. Ensley> ;Investigational New Drugs. 1998 Sep 1
• Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-r...
  Klumpp, T. R., Goldberg, S. L., Magdalinski, A. J., Mangan, K. F.> ;Bone Marrow Transplant. 1997 Aug
• Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
  Redei, I., Mangan, K. F., Ming, P. L., Mullaney, M. T., Rao, P. N., Goldberg, S. L., Klumpp, T. R.> ;Bone Marrow Transplant. 1997 Mar
• Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile.
  Goldberg, S. L., Shubert, J., Rao, A. K., Redei, I., Klumpp, T. R., Mangan, K. F.> ;Bone Marrow Transplant. 1996 Sep
• Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT.
  Klumpp, T. R., Herman, J. H., Schnell, M. K., Goldberg, S. L., Mangan, K. F.> ;Bone Marrow Transplant. 1996 Sep
• Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation.
  Klumpp, T. R., Herman, J. H., Innis, S., Pearlman, E., Culling, N., Kotz, K. W., Slachta, C., Goldberg, S. L., Mangan, K. F.> ;Bone Marrow Transplant. 1996 Jun
• Effect of hematopoietic growth factors on the rate of neutrophil recovery following peripheral blood stem cell transplantation.
  Klumpp, T. R., Goldberg, S. I., Magdalinski, A. J., Mangan, K. F.> ;Biol Blood Marrow Transplant. 1996 Feb
• Effect of granulocyte colony-stimulating factor on the rate of neutrophil engraftment following peripheral-blood stem-cell transplantation.
  Klumpp, T. R., Goldberg, S. L., Mangan, K. F.> ;J Clin Oncol. 1995 Aug
• Peripheral blood stem cell transplantation: from laboratory to clinical practice.
  Mangan, K. F.> ;Semin Oncol. 1995 Jun
• Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial.
  Klumpp, T. R., Mangan, K. F., Goldberg, S. L., Pearlman, E. S., Macdonald, J. S.> ;J Clin Oncol. 1995 Jun
• Join now to see all